CN1070411A - From disabled person's urine, extract the method for urinary trypsin inhibitor and G CFS - Google Patents

From disabled person's urine, extract the method for urinary trypsin inhibitor and G CFS Download PDF

Info

Publication number
CN1070411A
CN1070411A CN 91108119 CN91108119A CN1070411A CN 1070411 A CN1070411 A CN 1070411A CN 91108119 CN91108119 CN 91108119 CN 91108119 A CN91108119 A CN 91108119A CN 1070411 A CN1070411 A CN 1070411A
Authority
CN
China
Prior art keywords
urine
kaolin
cfs
trypsin inhibitor
sorbent material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 91108119
Other languages
Chinese (zh)
Other versions
CN1031577C (en
Inventor
张博达
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing University
Original Assignee
Nanjing University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing University filed Critical Nanjing University
Priority to CN 91108119 priority Critical patent/CN1031577C/en
Publication of CN1070411A publication Critical patent/CN1070411A/en
Application granted granted Critical
Publication of CN1031577C publication Critical patent/CN1031577C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

Extract the method for urinary trypsin inhibitor (UTI) and G CFS (CSF) a kind of disabled person's urine after having extracted urokinase (UK) simultaneously, this method is to make sorbent material with kaolin, under certain pH value, adsorb UTI and CSF simultaneously, the characteristics of this method are that technology is simple, cost is low, can utilize the production unit of former extraction UK to extract UTI and CSF.

Description

From disabled person's urine, extract the method for urinary trypsin inhibitor and G CFS
The present invention is a production method of extracting urinary trypsin inhibitor (being called for short UTI) and G CFS (being called for short CSF) a kind of disabled person's urine after having extracted urokinase (being called for short UK) simultaneously.
UTI is a kind of glycoprotein, suppresses trypsinase specifically, can be used for treating diseases such as acute pancreatitis, chronic recidivity pancreatitis, acute circulatory disorder.CSF has the effect that stimulates scavenger cell, can be used for treating diseases such as granulocytopenia, cancer.About from people's urine, extracting the method for UTI, the method (seeing Chinese patent CN86104618A) that Nippon Chemical Research K.K.'s good fortune justice is arranged at present and wait the people to invent, this method is the people to be urinated under condition of neutral pH foam, gather foam concentrate liquid, from weakly acidic concentrated solution, adsorb UTI and UKN(urine Pancreatic Kininogenase simultaneously with chitosan then), reach the purpose of extracting UTI and two products of UKN simultaneously.The advantage of this method is once to obtain UTI and two products of UKN from people urine, shortcoming be to equipment requirements than higher, one-time investment is bigger, the chitosan price is also somewhat expensive in addition, therefore, the production cost of UTI and UKN is than higher.Extracting CSF and UTI from people's urine has the patented method (the clear 61-59610 of Japanese Patent) of Japanese MORINAGA MILK INDUSTRY Co., LTD..This method is earlier the people to be urinated ultrafiltration and concentration, then with weak base anion exchanger absorption, uses the damping fluid branch wash-out of different concns again, obtains two products.The advantage of this method is the ion-exchanger repeated use of can regenerating, and can obtain two products of CSF and UTI respectively, but will urinate ultrafiltration and concentration, and handling a large amount of urine needs very big ultrafiltration apparatus, invests quite big.About the disabled person's urine after extracting UK, extract the method for UTI and two products of CSF more simultaneously, be not seen in report as yet.
The objective of the invention is to make full use of disabled person's urine of extracting behind the UK, therefrom once extract two products of UTI and CSF simultaneously.
Method of the present invention is to have extracted pH regulator to 5.5~6.5 of the disabled person's urine behind the urokinase with the diatomite adsorption method, allow disabled person's urine fully contact with the kaolin sorbent material, after treating that urinary trypsin inhibitor and G CFS are adsorbed onto on the kaolin, the useless urine of venting, wash sorbent material with water, the urinary trypsin inhibitor and the G CFS that will be adsorbed onto on the kaolin with ammonia soln elutes then, in elutriant, add ammonium sulfate precipitation, after leaving standstill, precipitation is used diatomite filtration, obtains containing diatomaceous urinary trypsin inhibitor and G CFS crude product.
In the invention process of present method, the inventor has done a large amount of cut-and-try works.In the screening of kaolin sorbent material, the inventor finds that K-6, K-7, K-8, K-9 and K-90 kaolin sorbent material that China Kaolin Co., Ltd produces can be used for extracting simultaneously UTI and CSF from disabled person's urine, be best with K-8 and two kinds of kaolin sorbent materials of K-9 especially wherein, these two kinds of kaolin sorbent materials are that China Kaolin Co., Ltd improves production according to inventor's requirement and suggestion.
The kaolin sorbent material has very strong adsorptive power, and at pH hour, the impurity of absorption is more, and at pH less than 5 o'clock, UTI and CSF easily are degraded to small molecules.The present invention has selected the adsorption conditions of pH5.5~6.5.Greater than 5.5 o'clock, the adsorptive capacity of UTI reduced at pH, and Xi Fu impurity is also less simultaneously, was main if only need to extract the CSF product, and pH can regulate more greatly, but can not be greater than 6.5, and pH was greater than 6.5 o'clock, and the adsorptive capacity of CSF also will reduce.In the time of need extracting two products simultaneously, be 5.5 the bests then with pH.
Kaolin adsorbs UTI and CSF from disabled person's urine speed is than faster.The speed of absorption is relevant with temperature, the temperature height, rate of adsorption is fast, generally whip attachment is 1~1.5 hour, summer the room temperature height, whip attachment 1 hour, winter temperature is low, whip attachment 1.5 hours.
The molecular weight of UTI is about 68000, and the molecular weight of CSF is about 42000, and under unsuitable working condition, the both easily is degraded to small molecules.The mode of production of the present invention causes under the situation of UTI and CSF macromolecules degradation in that people urine is rotten, and the macromole content that can guarantee UTI and CSF in the product is more than 80%.
The characteristics of method of the present invention are that technology is simple, and can utilizing at present fully, therefore domestic many places need not to increase what and just invest and can increase new product on the basis of original production UK with the simple production equipment of diatomite extraction UK.The sorbent material that uses is that china natural resources is abundant, cheap kaolin, and production cost is low.And,,, also can directly from protoplast's urine, extract UTI and CSF with the identical processing condition of the present invention if do not produce UK.
Below be embodiments of the invention:
Embodiment 1: the absorption property of kaolin sorbent material is measured, and will transfer to 5.5 with the pH that diatomite extracts the disabled person's urine behind the UK.Get 1 liter of disabled person's urine (pH=5.5) and increase mountain range earth adsorbing 10 gram, stirred 1.5 hours, draining useless urine after, with 50 ml distilled waters washing 1 time, use 50 milliliter 3% ammoniacal liquor (pH10.5~12.0) wash-out then, the content of UTI and CSF the results are shown in Table 1 in the mensuration elutriant
The absorption property of table 1 kaolin sorbent material
The trade mark UTI content (U) * CSF content (Colonyu) * *
K-6 4043 4.3×10 5
K-7 4107 4.3×10 5
K-8 4385 4.6×10 5
K-9 4413 4.6×10 5
K-90 3467 3.9×10 5
*The mensuration of UTI among the present invention is the U of 1UTI unit with the trypsinase of 4 units of every inhibition, measures and makes substrate with BAPNA.
*The Colonyu that tires of CSF cultivates (individual layer method) with the external agar of bone marrow cells in mice and measures calculating.Protein content converts with the O.D.280 value.
Embodiment 2: under the different pH, and the absorption property of kaolin sorbent material
Take diatomite and extract 5 liters of disabled person's urines behind the UK, be divided into 5 parts, 1 liter every part, transfer pH to 5.0 respectively, 5.5,6.0,6.5,7.0, each adds 10 gram K-9 kaolin sorbent materials, whip attachment 1.5 hours, draining useless urine after, wash once with 50 ml distilled waters respectively, use 50 milliliter 3% ammoniacal liquor wash-out then, measure UTI in each elutriant, CSF and protein content the results are shown in Table 2.
Under the different PH of table 2, the absorption property of kaolin sorbent material
PH 5.0 5.5 6.0 6.5 7.0
UTI(U) 4435 4423 4012 2715 1210
CSF(ColonyU) 4.6×10 5 4.6×10 5 4.6×10 5 4.6×10 5 4.1×10 5
Albumen egg (mg) 215 163 124 97 93
Embodiment 3: get 1 ton of disabled person's urine of extracting behind the UK respectively, 1 ton of Freshman urine stoste is transferred pH to 5.5 respectively, respectively add 10 kilograms in K-9 kaolin sorbent material, whip attachment 1.5 hours is behind the useless urine of venting, wash with water, add ammonium sulfate to saturation ratio and be 80% and saltout, after saltouing, precipitation is used diatomite filtration, obtains containing diatomaceous UTI and CSF crude product and is respectively 283 grams and 301 grams, behind crude product difference mixing, respectively take by weighing 2 grams, measure UTI respectively, CSF and Protein content the results are shown in Table 3.
UTI, CSF and protein that table 3 disabled person urine and former human urine extract
UTI(U) CSF(ColonyU) Protein (mg)
Disabled person's urine 23109 2.848×10 6 216
Former human urine 20797 2.751×10 6 228

Claims (7)

1, a kind of method of from extracted the disabled person's urine behind the urokinase, extracting urinary trypsin inhibitor and G CFS simultaneously, it is characterized in that and to have extracted between the pH regulator to 5.5 and 6.5 of the disabled person's urine behind the urokinase, allow disabled person's urine fully contact with the kaolin sorbent material, after treating that urinary trypsin inhibitor and G CFS are adsorbed onto on the kaolin, the useless urine of venting, wash sorbent material with water, the urinary trypsin inhibitor and the G CFS that will be adsorbed onto on the kaolin with ammonia soln elutes then, in elutriant, add ammonium sulfate precipitation, after leaving standstill, precipitation is used diatomite filtration, obtains containing diatomaceous urinary trypsin inhibitor and G CFS crude product.
2, method according to claim 1 is characterized in that this method also can be used for extracting urinary trypsin inhibitor and G CFS from crude urine.
3, according to claim 1 and 2 described methods, it is characterized in that the kaolin sorbent material is K-6, K-7, K-8, K-9 and K-90 kaolin sorbent material, wherein best with the effect of K-8 and two kinds of kaolin sorbent materials of K-9.
4, according to claim 1 and 2 described methods, the pH value that it is characterized in that regulating useless urine is more higher, and the impurity absorption amount is less, and the while adsorptive capacity of urinary trypsin inhibitor also reduces, and need extract two products simultaneously, is best with pH5.5.
5,, it is characterized in that the kaolin sorbent material consumption and the ratio of urine amount are that 1 gram is optimum than 100 milliliters according to claim 1 and 2 described methods.
6,, it is characterized in that the ammonia soln of wash-out urinary trypsin inhibitor and G CFS is an optimum with pH10.5~12.0 from the kaolin sorbent material according to claim 1 and 2 described methods.
7, according to claim 1 and 2 described methods, the saturation ratio of ammonium sulfate is 80% when it is characterized in that saltouing.
CN 91108119 1991-07-24 1991-07-24 Extraction of urine trypsin inhibitor and colonization agent from waste human urine Expired - Fee Related CN1031577C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 91108119 CN1031577C (en) 1991-07-24 1991-07-24 Extraction of urine trypsin inhibitor and colonization agent from waste human urine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 91108119 CN1031577C (en) 1991-07-24 1991-07-24 Extraction of urine trypsin inhibitor and colonization agent from waste human urine

Publications (2)

Publication Number Publication Date
CN1070411A true CN1070411A (en) 1993-03-31
CN1031577C CN1031577C (en) 1996-04-17

Family

ID=4909043

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 91108119 Expired - Fee Related CN1031577C (en) 1991-07-24 1991-07-24 Extraction of urine trypsin inhibitor and colonization agent from waste human urine

Country Status (1)

Country Link
CN (1) CN1031577C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102167739A (en) * 2011-02-15 2011-08-31 南昌市浩然生物医药有限公司 Method for purifying human urinary trypsin inhibitor by utilizing salt resistant mixed mode adsorbent
CN103074319A (en) * 2013-01-18 2013-05-01 扬州艾迪生物科技有限公司 Method for separating urokinase from human urinary trypsin inhibitor

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102167739A (en) * 2011-02-15 2011-08-31 南昌市浩然生物医药有限公司 Method for purifying human urinary trypsin inhibitor by utilizing salt resistant mixed mode adsorbent
CN103074319A (en) * 2013-01-18 2013-05-01 扬州艾迪生物科技有限公司 Method for separating urokinase from human urinary trypsin inhibitor
CN103074319B (en) * 2013-01-18 2014-06-11 扬州艾迪生物科技有限公司 Method for separating urokinase from human urinary trypsin inhibitor

Also Published As

Publication number Publication date
CN1031577C (en) 1996-04-17

Similar Documents

Publication Publication Date Title
US4946944A (en) Process for the selective extraction of metalloproteins from whey by adsorption and elution
CN111659354B (en) Hydroxyl graphene-nano silicon dioxide modified chitosan composite material and application thereof
JPH0585537B2 (en)
CN110614084A (en) Preparation method of composite adsorbent for wastewater treatment
CN1031577C (en) Extraction of urine trypsin inhibitor and colonization agent from waste human urine
Hernandez et al. Evaluation of ultrafiltration and adsorption to debitter grapefruit juice and grapefruit pulp wash
CN100358916C (en) Method for extracting high purity protein from cow milk or soybean waste water
CN103013951A (en) Method for extracting and purifying wheat germ lipase
CN103073623B (en) Separation and purification method for colistin sulfate
CN1927742A (en) Treatment method of soybean whey waste-water and product thereof
MXPA05010618A (en) Resin deacidification of citrus juice with high acid maintenance.
Ohe Antigenotoxic activities of chitin and chitosan as assayed by sister chromatid exchange
CN110372127A (en) The extraction element and technique of a kind of complete-dihydrogen orthophosphate of inositol six
CN209338245U (en) Drinking water mineral element selective removal system
CN210885600U (en) Extraction device of hexachlorocyclohexane hexa-holo-dihydrogen phosphate
CN113620429A (en) Carbon source supplementing process for sewage treatment based on food wastewater
CN108192799B (en) Composite clarifying agent and preparation method and clarifying method thereof
CN110255767A (en) The separation method of organic matter in a kind of natural water body
CN108083489A (en) A kind of waste water circulatory system
CN112978974B (en) Papermaking sewage treatment agent and preparation method and application thereof
CN109776641A (en) A kind of extraction process of vitamin B12 product
CN1597943A (en) Process for extracting oxalate oxidase from bran of wheat
CN114410724B (en) Paeonia ostii peptide with tyrosinase activity inhibiting function and preparation method and application thereof
Gump et al. Removal of unstable protein in grape juice and wine by adsorbents resins
CN102660525A (en) Method for preparing human urinary kallidinogenase crude product

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee